Related references
Note: Only part of the references are listed.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine
Smriti Iyengar et al.
PAIN (2017)
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference
Sofie Gydesen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Debbie L. Hay et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients
Peter J. Goadsby
BRAIN (2016)
Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
Rebekah L. Bower et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Parabrachial CGRP Neurons Control Meal Termination
Carlos A. Campos et al.
CELL METABOLISM (2016)
Amylin modulates the formalin-induced tonic pain behaviours in rats
C. S. Potes et al.
EUROPEAN JOURNAL OF PAIN (2016)
Calcitonin and Amylin Receptor Peptide Interaction Mechanisms INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS
Sang-Min Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells
Zahra Khoshdel et al.
NEUROPEPTIDES (2016)
Amylin-mediated control of glycemia, energy balance, and cognition
Elizabeth G. Mietlicki-Baase
PHYSIOLOGY & BEHAVIOR (2016)
Genetically and functionally defined NTS to PBN brain circuits mediating anorexia
Carolyn W. Roman et al.
NATURE COMMUNICATIONS (2016)
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
Joseph J. Gingell et al.
CELL DISCOVERY (2016)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Elucidating an Affective Pain Circuit that Creates a Threat Memory
Sung Han et al.
CELL (2015)
Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg et al.
CNS DRUGS (2015)
Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor
Jason M. Booe et al.
MOLECULAR CELL (2015)
Amylin Modulates the Mesolimbic Dopamine System to Control Energy Balance
Elizabeth G. Mietlicki-Baase et al.
NEUROPSYCHOPHARMACOLOGY (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2015)
Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activation
Debbie L. Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Amylin activates distributed CNS nuclei to control energy balance
Elizabeth G. Mietlicki-Baase et al.
PHYSIOLOGY & BEHAVIOR (2014)
Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT(a) function
T. Qi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Genetic identification of a neural circuit that suppresses appetite
Matthew E. Carter et al.
NATURE (2013)
Amylin Receptor Signaling in the Ventral Tegmental Area is Physiologically Relevant for the Control of Food Intake
Elizabeth G. Mietlicki-Baase et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?
James Barwell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Consequences of splice variation on Secretin family G protein-coupled receptor function
Sebastian G. B. Furness et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
R. J. Bailey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
Eric L. Moore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Control of energy homeostasis by amylin
Thomas A. Lutz
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis
D. Singh-Franco et al.
DIABETES OBESITY & METABOLISM (2011)
Pramlintide and the treatment of diabetes: a review of the data since its introduction
Lisa M. Younk et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding
E. L. Moore et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identification of central projections from amylin-activated neurons to the lateral hypothalamus
Catarina Soares Potes et al.
BRAIN RESEARCH (2010)
Mice Lacking the Neuropeptide α-Calcitonin Gene-Related Peptide Are Protected Against Diet-Induced Obesity
Christopher S. Walker et al.
ENDOCRINOLOGY (2010)
AMYLIN SUPPRESSES ACETIC ACID-INDUCED VISCERAL PAIN AND SPINAL C-FOS EXPRESSION IN THE MOUSE
X. Huang et al.
NEUROSCIENCE (2010)
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor
Joseph J. Gingell et al.
PEPTIDES (2010)
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity
Steve R. Smith et al.
DIABETES CARE (2008)
Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization
Rachel N. Danaher et al.
ENDOCRINOLOGY (2008)
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function
Tao Qi et al.
MOLECULAR PHARMACOLOGY (2008)
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
Jonathan D. Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK
Csilla Becskei et al.
BRAIN RESEARCH (2007)
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study
Steven R. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: A phase 2, randomized, placebo-controlled, dose-escalation study
Louis Aronne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors -: The role of receptor activity modifying protein 1
Debbie L. Hay et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacology of the human CGRP1 receptor in Cos 7 cells
Richard J. Bailey et al.
PEPTIDES (2006)
Pramlintide in the treatment of type 1 and type 2 diabetes mellitus
GJ Ryan et al.
CLINICAL THERAPEUTICS (2005)
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay et al.
MOLECULAR PHARMACOLOGY (2005)
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes
I Chapman et al.
DIABETOLOGIA (2005)
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects
T Heise et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors:: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS
DL Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis
WS Dhillo et al.
ENDOCRINOLOGY (2003)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Immunohistochemical localization of amylin in rat brainstem
L D'Este et al.
PEPTIDES (2000)
Amylin compared with calcitonin: competitive binding studies in rat brain and antinociceptive activity
V Sibilia et al.
BRAIN RESEARCH (2000)
Share Paper
